Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group.
about
Outcomes of intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 90 years or olderStroke epidemiology: advancing our understanding of disease mechanism and therapySignificant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).Clinical Outcome after Intra-Arterial Stroke Therapy in the Very Elderly: Why is it so Heterogeneous?Hospital admissions for stroke among the very old in the USA.Perceived wellbeing of patients one year post stroke in general practice--recommendations for quality aftercare.Patients' age as a determinant of care received following acute stroke: a systematic review.Atrial fibrillation in patients with ischemic stroke: A population-based study.Prevalence of impaired swallowing in institutionalized older people in taiwan.Dr John Rankin; his life, legacy and the 50th anniversary of the Rankin Stroke Scale.Differences in initial stroke severity between Mexican Americans and non-Hispanic whites vary by age: the Brain Attack Surveillance in Corpus Christi (BASIC) projectResearch priorities for high-quality geriatric emergency care: medication management, screening, and prevention and functional assessment.Age and gender as predictors of allied health quality stroke careStroke in the very old: a systematic review of studies on incidence, outcome, and resource use.Prestroke dementia is associated with poor outcomes after reperfusion therapy among elderly stroke patients.The safety and effectiveness of low-dose recombinant tissue plasminogen activator (0.6 mg/kg) therapy for elderly acute ischemic stroke patients (≥ 80 years old) in the pre-endovascular eraComparison of provision of stroke care in younger and older patients: findings from the South london stroke register.Intravenous thrombolytic treatment in the oldest old.Impact of acute ischemic stroke treatment in patients >80 years of age: the specialized program of translational research in acute stroke (SPOTRIAS) consortium experience.Spontaneous primary intraventricular hemorrhage: clinical features and early outcome.Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study.Thrombolytic therapy for acute ischaemic stroke in octogenarians: selection by magnetic resonance imaging improves safety but does not improve outcome.Admission clinical characteristics and early clinical outcomes among acute ischemic stroke patients.Acute stroke management in the elderly.Low admission serum albumin as prognostic determinant of 30-day case fatality and adverse functional outcome following acute ischemic stroke.Mortality, Recurrence, and Dependency Rates Are Higher after Acute Ischemic Stroke in Elderly Patients with Diabetes Compared to Younger Patients.Long-term outcomes of acute ischemic stroke in patients aged 80 years and older.Acute ischaemic stroke in patients aged 80 years and older: focus on the tolerability of thrombolytic agents.Effectiveness of alteplase in the very elderly after acute ischemic strokeStroke Outcomes in Thai Elderly Patients Treated with and without Intravenous ThrombolysisUse of oral anticoagulation therapy in atrial fibrillation after stroke: results from a nationwide registry.Thrombolysis, stroke-unit admission and early rehabilitation in elderly patients.Acute ischaemic stroke outcomes following mechanical thrombectomy in the elderly versus their younger counterpart: a retrospective cohort studyIschemic Stroke in the Elderly: Septuagenarians Versus Octogenarians.Ischemic stroke in the elderly: an overview of evidence.Risks and benefits of thrombolysis in the elderly.Plasticity of adult sensorimotor system in severe brain infarcts: challenges and opportunities.Safety and efficacy of thrombolysis with intravenous alteplase in older stroke patients.Neurogenic [corrected] and oropharyngeal dysphagia.Elderly patients and intra-arterial stroke therapy.
P2860
Q24646395-8FEAB4D3-0C95-42DD-A723-0B5629552484Q28395260-148E1B4E-6153-475F-854B-73D352F9CF82Q30996759-4C34937C-45DD-4183-8D28-80F6E7793D4DQ33569164-E283F5BB-A817-42BC-994B-E04D840441AAQ33650911-4C4095E6-30EE-4413-84DA-A5E2A9291496Q33858970-C2A24459-E5AD-4841-BF49-0B2902DD106CQ33951100-214EECBE-9D0C-427B-AD71-EF90714231A1Q34144002-4592DFB8-3FCC-4558-BD69-3444EE211674Q34730993-6C01925F-EEFF-4FAF-907C-BDDD90811F81Q34771337-6BDA3581-432A-48DF-84FA-B4377F320451Q34861632-0380EB10-7250-42F6-9EB9-65BBA539D275Q35051538-E3DF776B-644B-47A7-B528-AAA06E588021Q35163673-31101172-7EA3-4B60-8598-0756EBEFFD50Q35179656-4E5447B2-9540-4CE5-854A-A69CDC1FB1AEQ35848283-AEF0278B-5DA5-4F8F-BFDE-841D9164D0ABQ35943820-B6D570FD-7AD5-44E8-95F6-129D32167158Q35944977-D1673FFB-8D86-4FDC-AA47-AB83F86F3C61Q36119123-F777A6E9-22E6-41AA-BAEC-B9BC8067A284Q36195506-3059EC07-FD12-4077-AE44-B2DA98D53012Q36206588-8EB29686-48E7-4E60-8896-55640E55D027Q36226503-30E117CC-AB37-4AF0-8D4F-348C762EF577Q36227021-A558F167-DA7D-4F8F-A441-8C215FCB870AQ36680044-9CE23721-37A2-4755-8EBA-EEC300547E47Q36697519-A89DEE5B-B022-47AE-811C-CAACB651CE92Q36743297-578E3EB1-B927-49B0-83C8-8F045682520AQ37009438-2441CE5C-BAE5-448E-9B23-F2FB0EF30B31Q37041080-AAC8F34B-597A-47F9-B9E8-DB1F545558F5Q37079077-CA26169F-BA16-42DD-8E46-5A4CB731694AQ37088533-CF80A258-7486-4A4B-A5C0-34F75996D3E8Q37224387-C1779F43-CF34-4C86-8DA0-B2D809F5E923Q37375190-101163CF-2864-4265-B30E-8D87C266A0B0Q37571432-76C5FF9A-898D-4DE8-8B26-148DAD514467Q37657384-D876928F-E83E-40B4-8597-44BFAA47AC22Q37703760-BA53C75E-9856-4814-B10A-7F63E09F6965Q37724591-9609E473-6644-439D-BAD8-8E084DC6514FQ37977532-1598DE6A-3986-4B55-BA23-AE3E82263D83Q38006710-D967B617-7A60-489E-BA11-70058B6664C6Q38075828-6C1BFCB6-21EA-466E-94F4-AC96D0E61787Q38151799-A8463FB4-BFD8-45F2-B0C3-8B5C18D3A69FQ38160242-4F50D9E2-3334-4A5A-9387-10CD2D107650
P2860
Stroke in the very old : clinical presentation and determinants of 3-month functional outcome: A European perspective. European BIOMED Study of Stroke Care Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Stroke in the very old : clini ...... ED Study of Stroke Care Group.
@en
type
label
Stroke in the very old : clini ...... ED Study of Stroke Care Group.
@en
prefLabel
Stroke in the very old : clini ...... ED Study of Stroke Care Group.
@en
P2093
P1433
P1476
Stroke in the very old : clini ...... MED Study of Stroke Care Group
@en
P2093
A Di Carlo
A M Basile
D Inzitari
G Pracucci
G Trefoloni
P304
P356
10.1161/01.STR.30.11.2313
P407
P577
1999-11-01T00:00:00Z